Australian parents face similar barriers to delivering regular and nutritious meals as families did in the 1990s, amid increasing cost of living and time pressures that have been ignored for thirty years, according to new ...
Dec 4, 2023
0
0
To overcome problematic opioid use, traditional forms of opioid substitution therapy, such as methadone and oral buprenorphine, have become valuable tools. Research shows that patients receiving substitution therapy are more ...
Dec 1, 2023
0
0
Author Neil Gaiman said, "Escapist fiction is just that: fiction that opens a door, shows the sunlight outside."
Nov 29, 2023
0
0
Just over two years ago, terminally ill New Zealanders were given the right to request a medically assisted death with the End of Life Choice Act. But having assisted dying legally available doesn't mean everyone has the ...
Nov 29, 2023
0
0
New research from McMaster University has found that not only is virtual care a safe way to hold medical appointments, but that patients and physicians were able to use it appropriately and effectively with minimal guidance.
Nov 27, 2023
0
0
About 20% of all Germans live alone—and the number is increasing. This trend can also be observed in most other Western countries. However, contrary to prevailing prejudices, living alone does not necessarily mean isolation ...
Nov 24, 2023
0
26
Breath-holding spells are common in young children and are benign. Yet children often undergo unnecessary diagnostic interventions when seeking medical care. This is because there are no national or international guidelines ...
Nov 24, 2023
0
0
For many, Thanksgiving can be a source of anxiety, conjuring up thoughts of hectic travel schedules, long hours in the kitchen and uncomfortable conversation with family members.
Nov 22, 2023
0
1
A new study led by University of Melbourne researchers has discovered a link between a new gene pathway and structural brain anomalies in some people who stutter into adulthood, opening up promising research avenues to enhance ...
Nov 20, 2023
0
81
Two stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of the disease, and a surprising study showing that mild cognitive impairment is wildly underdiagnosed.
Nov 20, 2023
0
0
